Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Study
Authors Husseini L, Jung J, Boess N, Kruse N, Nessler S, Stadelmann C, Metz I, Haupts M, Weber MS Journal Neurology: Neuroimmunology & Neuroinflammation Citation Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200279. Abstract Objectives: To assess neurofilament light chain serum (sNfL) levels in patients with secondary progressive multiple sclerosis (SP-MS). Methods: Using
